Cargando…

A prospective study of neurofibromatosis type 1 cancer incidence in the UK

Neurofibromatosis type 1 (NF1) is an autosomal dominant condition affecting around one in 3000 live births. The manifestations of this condition are extremely variable, even within families, and genetic counselling is consequently difficult with regard to prognosis. Individuals with NF1 are acknowle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, L, Thompson, D, Easton, D, Ponder, B, Ponder, M, Frayling, I, Baralle, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360616/ https://www.ncbi.nlm.nih.gov/pubmed/16786042 http://dx.doi.org/10.1038/sj.bjc.6603227

Ejemplares similares

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
por: Lesueur, F, et al.
Publicado: (2006)

Interactions between genes involved in the antioxidant defence system and breast cancer risk
por: Oestergaard, M Z, et al.
Publicado: (2006)

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
por: Benusiglio, P R, et al.
Publicado: (2006)

Common germ-line polymorphism of C1QA and breast cancer survival
por: Azzato, E M, et al.
Publicado: (2010)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours
por: Özdağ, H, et al.
Publicado: (2002)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US–UK study
por: Little, M P, et al.
Publicado: (2014)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
por: Reiman, A, et al.
Publicado: (2011)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Role of MC1R variants in uveal melanoma
por: Hearle, N, et al.
Publicado: (2003)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

A physical analysis of the Y chromosome shows no additional deletions, other than Gr/Gr, associated with testicular germ cell tumour
por: Linger, R, et al.
Publicado: (2007)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
por: Anderson, E, et al.
Publicado: (2008)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types
por: Therkildsen, Christina, et al.
Publicado: (2017)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells
por: Bader, S A, et al.
Publicado: (2007)

Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins
por: Barrett, J H, et al.
Publicado: (2003)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
por: Phelan, C M, et al.
Publicado: (2014)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management
por: Pulliam, Steven, et al.
Publicado: (2022)

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients
por: Wong, S Q, et al.
Publicado: (2015)

Impact of HER2 copy number in IHC2+/FISH-amplified breast cancer on outcome of adjuvant trastuzumab treatment in a large UK cancer network
por: Borley, A, et al.
Publicado: (2014)

Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1
por: Gregório, Cleandra, et al.
Publicado: (2020)

Primary Progressive Multiple Sclerosis in a Portuguese Patient With Neurofibromatosis Type 1
por: Carvalho, Inês, et al.
Publicado: (2021)

Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications
por: Ponder, BAJ, et al.
Publicado: (2006)

The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types
por: Forget, M-A, et al.
Publicado: (2007)

Role of simian virus 40 in cancer incidence in solid organ transplant patients
por: Paracchini, V, et al.
Publicado: (2006)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
por: Sodha, N, et al.
Publicado: (2002)

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

A Rare Case of the Coexistence of Pancreaticobiliary Maljunction and Gastrointestinal Tumor in Neurofibromatosis Type 1
por: Tanaka, Rie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pnvuvbhaubslk71l9d8oh18krv